Literature DB >> 30824378

Associating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency?

Rhonda D Szczesniak1, Jonathan D Cogen2, Margaret Rosenfeld2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30824378      PMCID： PMC7020339          DOI： 10.1016/j.jcf.2019.02.008

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  4 in total

Review 1.  The cost of dichotomising continuous variables.

Authors:  Douglas G Altman; Patrick Royston
Journal:  BMJ       Date:  2006-05-06

2.  Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review.

Authors:  Ranjani Somayaji; Michael D Parkins; Anand Shah; Stacey L Martiniano; Michael M Tunney; Jennifer S Kahle; Valerie J Waters; J Stuart Elborn; Scott C Bell; Patrick A Flume; Donald R VanDevanter
Journal:  J Cyst Fibros       Date:  2019-01-30       Impact factor: 5.482

Review 3.  Treatment of lung infection in patients with cystic fibrosis: current and future strategies.

Authors:  Gerd Döring; Patrick Flume; Harry Heijerman; J Stuart Elborn
Journal:  J Cyst Fibros       Date:  2012-11-06       Impact factor: 5.482

4.  Reducing bias through directed acyclic graphs.

Authors:  Ian Shrier; Robert W Platt
Journal:  BMC Med Res Methodol       Date:  2008-10-30       Impact factor: 4.615
  4 in total
  1 in total

1.  Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis.

Authors:  Donald R VanDevanter; Sonya L Heltshe; Jay B Hilliard; Michael W Konstan
Journal:  J Cyst Fibros       Date:  2020-06-04       Impact factor: 5.482
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.